Economic Evaluation of Gemcitabine Alone and in Combination with Cisplatin in the Treatment of Nonsmall Cell Lung Cancer

Author： Lees M.

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.20, Iss.5, 2002-01, pp. : 325-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer

By Vansteenkiste Johan Canon Jean-Luc Riska Henrik Pirker Robert Peterson Patrick John William Mali Pekka Lahn Michael

Investigational New Drugs, Vol. 23, Iss. 3, 2005-06 ,pp. : 263-269

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer

By Nagel Sylke Califano Raffaele Thatcher Nicholas Blackhall Fiona

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 18, 2007-12 ,pp. : 3265-3275

Informa Healthcare

Access to resources Recommend Favorite

Silencing of X-linked Inhibitor of Apoptosis Decreases Resistance to Cisplatin and Paclitaxel But Not Gemcitabine in Non-small Cell Lung Cancer

By Liu Y Wu X Sun Y Chen F

The Journal of International Medical Research, Vol. 39, Iss. 5, 2011-09 ,pp. : 1682-1692

Field House Publishing

Access to resources Recommend Favorite

Gemcitabine in non-small cell lung cancer

By Cappuzzo Federico Crinò Lucio

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 6, 2002-06 ,pp. : 745-753

Informa Healthcare

Access to resources Recommend Favorite

Novel combination chemotherapy in the treatment of non-small cell lung cancer

By Sekine I. Saijo N.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 6, 2000-09 ,pp. : 1131-1161

Informa Healthcare

Access to resources Recommend Favorite